Certain blood proteins detectable years before diagnosis could potentially serve as biomarkers for predicting liver cancer, according to a new study. This discovery could offer new hope for a cancer often diagnosed at a late stage when treatment options are typically limited.
“ Liver cancer rates are rapidly increasing, and liver cancer has a high mortality rate,” Xinyuan Zhang, postdoctoral research fellow at Brigham and Women’s Hospital and the study’s lead author, said in a press release. “But if we can diagnose it early, therapeutic interventions can be potentially curative.”
